Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-05The Effects of Glucagon on Hepatic Metabolism
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase-1, Parallel-Design, Open-Label, Randomized, Multiple-Dose Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3549492 in Healthy Participants With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-03-04Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity
-
CLINICAL_TRIALS study record update · 2026-03-04Epigenetic Signature of Advance Glycation End Products (AGE) and Skin Autofluorescence As a Risk Predictor in Metabolically Healthy and Unhealthy Obese Adults
-
CLINICAL_TRIALS study record update · 2026-03-04Understanding Alterations in Mast Cell and Macrophage Infiltration, as Well as Micro Vessel Density, May Throw Light on the Early Events Leading to Gastric Carcinogenesis in Obesity.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-04Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Food Intake: A Randomized, Double-Blind, Sham-Controlled Crossover Study
-
CLINICAL_TRIALS study record update · 2026-03-03Enhancing Weight Loss in a Digital Intervention Among Adults With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-03-03A Phase II Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist
-
CLINICAL_TRIALS study record update · 2026-03-03A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Pivotal Study to Assess the Efficacy of Revita® Duodenal Mucosal Resurfacing (DMR) on Body Weight Maintenance in Participants With Obesity and Who Have Achieved at Least 15% Weight Loss on Tirzepatide Obesity Pharmacotherapy
-
CLINICAL_TRIALS study record update · 2026-03-03A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Retatrutide Treatment in the Maintenance of Weight Reduction in Individuals With Obesity
-
CLINICAL_TRIALS study record update · 2026-03-03Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea
-
CLINICAL_TRIALS study record update · 2026-03-03Effect of a Structured Clinical and Pharmacological Management Strategy on Cardiovascular Risk Factors in Adult Patients in Routine Clinical Practice: A Pseudo-Experimental Before-and-After Study
-
CLINICAL_TRIALS study record update · 2026-03-03Effect of Non-invasive Vagal Nerve Stimulation on Selected Outcomes in Central Obesity
-
CLINICAL_TRIALS study record update · 2026-03-03The Effect of Cognitive Behavioral Therapy-Based and Motivational Interviewing-Supported Psychoeducation on Emotional Eating and Psychological Resilience in Individuals With Obesity
-
CLINICAL_TRIALS study record update · 2026-03-02A Novel Precision Medicine Approach For Obesity: A Randomized, Multi-Center Trial
-
CLINICAL_TRIALS study record update · 2026-03-02Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-03-02Understanding the Dietary Adjustments Following GLP-1 Agonist Treatment: The GLaD Feasibility Study
-
CLINICAL_TRIALS study record update · 2026-03-02Endoscopic Ultrasound Shear Wave Elastography: A Novel Tool for Fibrosis Screening in Patient With Elevated Body Mass Index and Suspected Non-Alcoholic Fatty Liver Disease or Steatohepatitis
-
CLINICAL_TRIALS study record update · 2026-03-02A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
-
CLINICAL_TRIALS study record update · 2026-03-02Use of Sedation-Free Transnasal Endoscopy to Improve Access and Lower Costs of Endoscopic Evaluations in a Bariatric Medical and Surgical Program
-
CLINICAL_TRIALS study record update · 2026-03-02Vanderbilt University Medical Center
-
CLINICAL_TRIALS study record update · 2026-03-02Intermittent Fasting in Adults With Type 1 Diabetes
-
CLINICAL_TRIALS study record update · 2026-03-02A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Reduction With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight and With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-03-02Effect of Spirulina Platensis Supplementation and Calorie Restriction on Anthropometric, Body Composition, Lipid Profiles, Insulin Resistance, Stress Oxidative Biomarkers In Obese Men: A Randomized Controlled Trial Protocol Study
-
CLINICAL_TRIALS study record update · 2026-02-27A PHASE 1, OPEN-LABEL, RANDOMIZED, SINGLE DOSE, PARALLEL GROUP STUDY TO ASSESS RELATIVE BIOAVAILABILITY OF PF-08653944 WHEN ADMINISTERED ACROSS DIFFERENT INJECTION SITES IN ADULTS WITH OVERWEIGHT OR OBESITY